NCT03623334 Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy Status COMPLETED Phase NA
NCT03621982 Study of ADCT-301 in Patients With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03616522 A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase N/A
NCT03614065 Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC Status UNKNOWN Phase PHASE2
NCT03613467 Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients Status COMPLETED Phase N/A
NCT03611738 Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03607188 Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT03607149 Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies Status COMPLETED Phase PHASE4
NCT03603652 NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung Status TERMINATED Phase NA
NCT03603262 Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC Status UNKNOWN Phase PHASE1
NCT03598517 High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer Status UNKNOWN Phase NA
NCT03594747 A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer Status COMPLETED Phase PHASE3
NCT03583723 Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (LARTIA Trial) Status UNKNOWN Phase NA
NCT03583086 Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03576937 Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study Status COMPLETED Phase N/A
NCT03576131 GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT03573947 Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC Status COMPLETED Phase PHASE2
NCT03565003 A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China Status COMPLETED Phase PHASE1/PHASE2